Thinking Chemically to Discover New Targeted Cancer Drugs
About a third of all cancers are driven by mutations in RAS genes. Learn how NCI funding is helping Dr. Kevan Shokat develop drugs that inactivate molecular drivers of cancer such as RAS.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1126608/syndication
- Syndication ID: 18385
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Wednesday, December 19, 2018 at 06:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:41 PM
Embed Code Snippet
To get the embed code snippet please Login.
